Clinical Trial Update: POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.

View source ↗

Summary

A clinical trial update describing the planned assessment of the effectiveness and tolerability of luseogliflozin in patients with Type 2 diabetes, with the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Luseogliflozin (luseogliflozin)

Snippet

Sponsor: Servier Russia | Conditions: Type 2 Diabetes Mellitus | Status: NOT_YET_RECRUITING